CHICAGO/NEW YORK, Sept 28 (Reuters) - Abbott Laboratories
veteran Richard Gonzalez may get a pass on his
overstated educational credentials as investors focus instead on
his 30-year-plus track record at the healthcare giant, analysts
said on Friday.
Read more